CAR-T cells are more affected than T lymphocytes by mechanical constraints: A microfluidic-based approach
Financiación H2020 / H2020 Funds
Resumen: Aims: CAR-T cell therapy has attracted considerable attention in recent years owing to its well-known efficacy against haematopoietic malignancies. Nevertheless, this immunotherapy fails against solid tumours due to hostile conditions found in the tumour microenvironment. In this context, many relevant biochemical factors have been thoroughly studied, but crucial mechanical cues have been underestimated. Main methods: We developed an innovative approach using microfluidic devices, which recreate the biomechanical aspects of solid tumours. Using these platforms, we quantified immune cell migration (T and CAR-T cells) under different confinement conditions.
Key findings: We found that both CAR-T cell and T cell velocities are affected by the biomechanical and chemical cues studied, which are closely related to those found in solid tumours. Under biochemical stimulus-free conditions, the velocity of T cells is independent of the width of the microchannel, whereas the velocity of CAR-T cells is greatly reduced in the highest confinement channels. When chemoattractants or tumour cells are added, immune cells display increased confined migration velocity. However, in the presence of immunosuppressive chemokines, T cells become slower, whereas CAR-T cells significantly increase their velocity via a chimeric cytokine receptor. Significance: Our approach contributes to a better understanding of immune cell migration and the influence of mechanical constraints, which will allow the testing of new ways to improve CAR-T cell trafficking into solid tumours. Therefore, our study revealed that the migratory behaviour of CAR-T cells differs from that of T cells under confined conditions and that biomechanical cues, such as cell deformability caused by confinement, can influence the correct infiltration of immune cells into solid tumours during the immune response.

Idioma: Inglés
DOI: 10.1016/j.lfs.2024.123335
Año: 2024
Publicado en: LIFE SCIENCES 363 (2024), 123335 [12 pp.]
ISSN: 0024-3205

Factor impacto JCR: 5.1 (2024)
Categ. JCR: PHARMACOLOGY & PHARMACY rank: 44 / 352 = 0.125 (2024) - Q1 - T1
Categ. JCR: MEDICINE, RESEARCH & EXPERIMENTAL rank: 44 / 195 = 0.226 (2024) - Q1 - T1

Factor impacto SCIMAGO: 1.315 - Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1) - Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1) - Medicine (miscellaneous) (Q1)

Financiación: info:eu-repo/grantAgreement/ES/AEI/FJC2021-048046-I
Financiación: info:eu-repo/grantAgreement/EC/H2020/101018587/EU/Individual and Collective Migration of the Immune Cellular System/ICoMICS
Financiación: info:eu-repo/grantAgreement/ES/MEFP/FPU21/06003
Financiación: info:eu-repo/grantAgreement/ES/MICINN/PTA2020-018510-I/AEI/10.13039/501100011033
Tipo y forma: Article (Published version)
Área (Departamento): Área Inmunología (Dpto. Microb.Ped.Radio.Sal.Pú.)
Área (Departamento): Área Bioquímica y Biolog.Mole. (Dpto. Bioq.Biolog.Mol. Celular)
Área (Departamento): Área Mec.Med.Cont. y Teor.Est. (Dpto. Ingeniería Mecánica)

Exportado de SIDERAL (2025-10-17-14:33:55)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
articulos > articulos-por-area > mec._de_medios_continuos_y_teor._de_estructuras
articulos > articulos-por-area > bioquimica_y_biologia_molecular
articulos > articulos-por-area > inmunologia



 Notice créée le 2025-01-24, modifiée le 2025-10-17


Versión publicada:
 PDF
Évaluer ce document:

Rate this document:
1
2
3
 
(Pas encore évalué)